期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

唐氏综合征的产前筛查

下载PDF
导出
摘要 唐氏综合征是足月新生儿最常见的常染色体病，占先天智力障碍的50％，群体发病率为12．3/万，目前国内外临床上广泛应用母体血清标志物及超声检查等无创性检查指标，结合孕妇年龄、体重等评估妊娠妇女患唐氏综合征胎儿的风险，对筛查阳性者提供产前诊断进行遗传学分析，以减少异常或畸形儿童出生。
作者 黄伟蓉 邱莉娜
机构地区 福建省漳州市中医院
出处 《中国保健营养（临床医学学刊）》 2010年第6期174-175,共2页 China Health Care Nutrtion
关键词 唐氏综合征 产前筛查 血清标志物 超声检查
分类号 R445.1 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献7

  • 1郑明明,胡娅莉.唐氏综合征的产前筛查及其进展[J].中国实用妇科与产科杂志,2006,22(5):395-397. 被引量：7
  • 2孙振高,连方.唐氏综合征的产前筛查[J].山东卫生,2006(11):55-56. 被引量：1
  • 3景春梅,王应雄.唐氏综合征产前筛查的研究进展[J].国外医学（计划生育．生殖健康分册）,2006,25(6):314-318. 被引量：3
  • 46oodburn SF, Yates JR, Raggatt PR, et al. Second -trimester matemal serum screening using alpha fetoprotein, human ehorioniegonadotropin and unconjugated oestriol: experience of a regional prograrmme[J]. Prenat Diagn, 1994, 14: 391-402.
  • 5Pajkrt E, Mol BW. Van Lith Jm Downs syndrome by fetal et al. Screening for nuchal translucency measurement in a high--risk population[J]. Ultrasound Obstet Gynecol. 1998, 12 (3): 156-162.
  • 6王铮,黄国香,胡边.唐氏综合征产前筛查方法进展[J].中国优生与遗传杂志,2005,13(4):127-128. 被引量：13
  • 7RCOG. The Royal College of Obstetricians and Gynaecologists Report. RCOG,Working Party on Markers and the Detection of Down S Syndrome, London: RCOG1993: 8-14.

二级参考文献48

  • 1Chao AS, Chung CL,Wu CD,et al. Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population[J]. Acta Obstet Gynecol Scand , 1999,78(5):393-397.
  • 2Pajkrt E, Mol BW, van Lith JM, et al.Screening for Downs syndrome by fetal nuchal translucency measurement in a high-risk population[J]. Ultrasound Obstet Gynecol,1998,12(3):156-162.
  • 3Worteboer JM, Mdewolf TH, Vdrschuren-Bemlmans CC, et al. Treads in live birth prevalence of Down syndrome in the Northern Nether-lands 1987-96:the impact of screening and prenatal diagnosis[J]. Prenat Diagn,2000,20:709-713.
  • 4Robert O, Eric J, Gurmit S, et al. Serum screening for Down syndrome and adversa pregnancy outcomes: a case-controlled study[J]. Prenat Diagn, 2000,20:96-99.
  • 5Wenstrom KD.Second trimester maternal serum CA-125 versus triol in the multiple-marker screening test for Down syndrome[J]. Obster Gynicol,1997.89(3):359-363.
  • 6Bogart MH, Pandian MR, Jones OW, et al. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities[J]. Prenat Diagn,1987,7:623-630.
  • 7Goodburn SF, Yates JR, Raggatt PR, et al. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotropin and unconjugated oestriol: experience of a regional programme[J]. Prenat Diagn,1994,14:391-402.
  • 8Bersinger NA, Brizot ML, Johnson A, et al. First trimester maternal serum pregnancy associated plasma protein A and pregnancy specific betal -glycoprotein in fetal trisomies[J]. Br J Obstet Gynecol,1994,101:970-974.
  • 9Wald NJ, Cuckle HS, Denson JW, et al. Maternal serum screening for Down's syndrome in early pregnancy[J]. BMJ,1988,297:883-887.
  • 10McDuffie RS Jr , Haverhamp AD, Stark CF , et al . Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated estriol :two-year experience in a health maintenance organization[J]. J Matern Fetal Med,1996,5:70-73.

共引文献19

中国保健营养（临床医学学刊）
2010年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部